Northeast Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$369K Hold
6,407
0.01% 164
2026
Q1
$389K Buy
6,407
+232
+4% +$13.5K 0.02% 152
2025
Q4
$333K Sell
6,175
-530
-8% -$25.5K 0.01% 157
2025
Q3
$302K Sell
6,705
-1,255
-16% -$58.6K 0.01% 154
2025
Q2
$368K Hold
7,960
0.02% 146
2025
Q1
$485K Sell
7,960
-679
-8% -$39.6K 0.02% 131
2024
Q4
$489K Sell
8,639
-300
-3% -$16.8K 0.02% 133
2024
Q3
$463K Sell
8,939
-207
-2% -$9.71K 0.02% 139
2024
Q2
$380K Sell
9,146
-795
-8% -$35.6K 0.02% 147
2024
Q1
$539K Sell
9,941
-1,600
-14% -$81.5K 0.03% 134
2023
Q4
$592K Sell
11,541
-720
-6% -$37.8K 0.03% 124
2023
Q3
$712K Buy
12,261
+1,800
+17% +$110K 0.04% 117
2023
Q2
$669K Sell
10,461
-35
-0.3% -$2.35K 0.04% 117
2023
Q1
$727K Sell
10,496
-35
-0.3% -$2.47K 0.04% 111
2022
Q4
$758K Sell
10,531
-1,709
-14% -$129K 0.05% 110
2022
Q3
$870K Sell
12,240
-50
-0.4% -$3.63K 0.06% 98
2022
Q2
$946K Sell
12,290
-1,056
-8% -$80.4K 0.06% 102
2022
Q1
$975K Sell
13,346
-231
-2% -$15.5K 0.05% 113
2021
Q4
$847K Buy
13,577
+146
+1% +$8.56K 0.04% 116
2021
Q3
$795K Buy
13,431
+680
+5% +$44.8K 0.04% 118
2021
Q2
$852K Sell
12,751
-907
-7% -$59.1K 0.05% 114
2021
Q1
$862K Sell
13,658
-109
-0.8% -$6.78K 0.05% 112
2020
Q4
$854K Sell
13,767
-573
-4% -$35.2K 0.05% 108
2020
Q3
$865K Sell
14,340
-81
-0.6% -$4.88K 0.06% 103
2020
Q2
$848K Buy
14,421
+820
+6% +$49K 0.06% 95
2020
Q1
$758K Sell
13,601
-531
-4% -$32.5K 0.07% 91
2019
Q4
$907K Sell
14,132
-179
-1% -$10.3K 0.07% 102
2019
Q3
$726K Sell
14,311
-10,955
-43% -$515K 0.06% 108
2019
Q2
$1.15M Sell
25,266
-66,517
-72% -$3.1M 0.09% 97
2019
Q1
$4.38M Sell
91,783
-64,345
-41% -$3.21M 0.37% 63
2018
Q4
$8.12M Sell
156,128
-134,208
-46% -$7.21M 0.78% 41
2018
Q3
$18M Sell
290,336
-3,487
-1% -$207K 1.44% 27
2018
Q2
$16.3M Sell
293,823
-17,117
-6% -$924K 1.38% 27
2018
Q1
$19.7M Buy
310,940
+8,252
+3% +$531K 1.74% 18
2017
Q4
$18.5M Buy
302,688
+29,772
+11% +$1.86M 1.56% 24
2017
Q3
$17.4M Buy
272,916
+5,960
+2% +$348K 1.54% 25
2017
Q2
$14.9M Sell
266,956
-2,755
-1% -$150K 1.35% 29
2017
Q1
$14.7M Sell
269,711
-2,821
-1% -$155K 1.37% 29
2016
Q4
$15.9M Sell
272,532
-14,036
-5% -$767K 1.53% 24
2016
Q3
$15.5M Buy
286,568
+6,803
+2% +$437K 1.54% 23
2016
Q2
$20.6M Buy
279,765
+28,494
+11% +$2.01M 2.07% 16
2016
Q1
$16.1M Buy
251,271
+23,071
+10% +$1.45M 1.65% 23
2015
Q4
$15.7M Buy
228,200
+28,447
+14% +$1.88M 1.63% 24
2015
Q3
$11.8M Buy
199,753
+21,472
+12% +$1.36M 1.28% 30
2015
Q2
$11.9M Buy
178,281
+28,301
+19% +$1.87M 1.2% 33
2015
Q1
$9.67M Buy
149,980
+30,288
+25% +$1.9M 0.95% 42
2014
Q4
$7.07M Buy
119,692
+28,387
+31% +$1.6M 0.69% 50
2014
Q3
$4.67M Buy
91,305
+48,807
+115% +$2.44M 0.47% 60
2014
Q2
$2.06M Buy
+42,498
New +$2.09M 0.21% 84
2013
Q4
Sell
-5,166
Closed -$239K 163
2013
Q3
$239K Buy
+5,166
New +$227K 0.03% 147

Other funds holding BMY

Northeast Investment Management's BMY Position: Q2 2026 in Review

Northeast Investment Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 6,407 shares worth $369K. The position accounts for 0.01% of the portfolio, ranked #164.

Northeast Investment Management first reported a position in BMY in Q3 2013 and has held it in 50 quarters since. The position peaked at $20.6M in Q2 2016. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Northeast Investment Management held 6,407 shares of Bristol-Myers Squibb worth $369K as of Q2 2026.
  • Northeast Investment Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.01% of Northeast Investment Management's portfolio in Q2 2026, its #164 holding.
  • Northeast Investment Management first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 50 quarters since.
  • Northeast Investment Management's Bristol-Myers Squibb position peaked at $20.6M in Q2 2016.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Northeast Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.